SCHEMBL27747320

SCHEMBL27747320

NC(=O)N(c1cccc(C(F)(F)F)c1)c1ccc(Br)cc1F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MPO P05164 1/20 0.39
DGAT1 O75907 1/20 0.39
GRIK1 P39086 1/20 0.37
CES2 O00748 1/20 0.37
SIRT2 Q8IXJ6 1/20 0.36
CTSL P07711 1/20 0.36
MAPT P10636 3/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
RECQL P46063 1/20 0.36
GPR35 Q9HC97 1/20 0.35
ALDH1A1 P00352 3/20 0.35
KIF11 P52732 2/20 0.35
HTR3E A5X5Y0 1/20 0.35
HTR3B O95264 1/20 0.35
HTR3A P46098 1/20 0.35
HTR3D Q70Z44 1/20 0.35
HTR3C Q8WXA8 1/20 0.35
LMNA P02545 2/20 0.34
HTT P42858 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7613082 0.85 MPO (0.51) MPOGRIK1MEN1KMT2AGPR35
SCHEMBL27760010 0.82 DGAT1 (0.41) MPODGAT1GRIK1CES2MEN1
SCHEMBL5606524 0.81 CES2 (0.50) CES2MAPTMEN1KMT2ARECQL
SCHEMBL27657555 0.80 DGAT1 (0.39) DGAT1SIRT2
SCHEMBL27721413 0.79 P2RX1 (0.43) CES2MAPTMEN1KMT2AALDH1A1
SCHEMBL27742328 0.78 P2RX1 (0.44) MPOGRIK1CES2MEN1KMT2A
SCHEMBL6772436 0.78 GPR35 (0.41) MPOGRIK1CTSLMAPTMEN1
SCHEMBL31337191 0.78 GPR35 (0.41) MPOGRIK1CTSLMAPTMEN1
SCHEMBL28217598 0.77 PTGIR (0.46) CES2MAPTMEN1KMT2AKIF11
SCHEMBL27653559 0.75 BAZ2B (0.40) CES2MAPTALDH1A1KIF11EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101466710-A Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis BAYER HEALTHCARE LLC (US) 2009-06-24 CN disclosed